Lipid Nanoparticle-Assisted Mir29a Delivery Based on Core-Shell Nanofibers Improves Tendon Healing by Cross-Regulation of the Immune Response and Matrix Remodeling

Wei Chen,Yi Chen,Yiming Ren,Cangjian Gao,Chao Ning,Haotian Deng,Peiqi Li,Yang Ma,Hao Li,Liwei Fu,Guangzhao Tian,Zhen Yang,Xiang Sui,Zhiguo Yuan,Quanyi Guo,Shuyun Liu
DOI: https://doi.org/10.1016/j.biomaterials.2022.121888
IF: 14
2022-01-01
Biomaterials
Abstract:Inferior healing and peritendinous adhesions are the major clinical problems following Achilles tendon injury, leading to impaired motor function and an increased risk of re-rupture. These complications are presumed to be inextricably linked to inflammation and fibroscar formation. Here, microRNA29a is identified as a promising therapeutic target for tendon injury through the cross-regulation of the immune response and matrix remodeling. MiR29a-LNPs were successfully prepared by microfluidic technology. They are then loaded into the core-shell nanofibers to achieve local delivery in the injured tendon, where the shell layer is composed of PELA for anti-adhesion. Our studies reveal that miR29a regulates collagen synthesis and NF-κB activation in tenocytes, and promotes macrophage polarization by inhibiting the inflammasome pathway. In vivo studies of the Achilles tendon-rupture model indicate the best repair in the miR29a group, as evidenced by superior collagen composition and alignment, higher mechanical strength, and better functional recovery. In conclusion, a functionalized anti-adhesive membrane that promotes nascent tendon matrix remodeling and improves the regenerative immune microenvironment is developed for the treatment of tendon injury.
What problem does this paper attempt to address?